StockData
MIRA Pharmaceuticals, Inc. logo

MIRA Pharmaceuticals, Inc. (MIRA) KPIs and segments

MIRANasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 6/30
$0.59−0.05 (-7.66%)

Close on Nov 18, 2026Market cap $24.84MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive MIRA Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to MIRA Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?